Claroid began its journey in 2018 with a bold mission of becoming a leader in the pharmaceutical manufacturing sector. Guided by the founder's vision and purpose, Claroid , over the years, has scaled new heights in the pharmaceutical manufacturing sector and today provides medicines for safer and cost- effective living standards to major parts of the world.

This modern plant is set over an area of 12,332 sqm with a built-up area of 3,754sqm. The unit is designed as per international regulatory standards like USFDA, MHRA, PIC/s & EU-GMP.
Claroid is well equipped to manufacture Tablets, Capsules, and Topicals such as Ointments, Creams, and Gels.

Its estimated capacities considering single shift for Tablet is : 1200 million (P/A), for Hard Gelatine Capsule is : 300 million (P/A) and for Ointment/Cream is : 3.0 million (P/A).

Claroid  looks to the future with ever higher goals and ambitions and with its unwavering focus on service and quality is strategically poised to grow even further in the years ahead.